Invention Grant
- Patent Title: 4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
-
Application No.: US14122063Application Date: 2012-05-21
-
Publication No.: US09669034B2Publication Date: 2017-06-06
- Inventor: Ulrich Lücking , Rolf Bohlmann , Arne Scholz , Gerhard Siemeister , Mark Jean Gnoth , Ulf Bömer , Dirk Kosemund , Philip Lienau , Gerd Rühter , Carsten Schultz-Fademrecht
- Applicant: Ulrich Lücking , Rolf Bohlmann , Arne Scholz , Gerhard Siemeister , Mark Jean Gnoth , Ulf Bömer , Dirk Kosemund , Philip Lienau , Gerd Rühter , Carsten Schultz-Fademrecht
- Applicant Address: DE Monheim
- Assignee: BAYER INTELLECTUAL PROPERTY GMBH
- Current Assignee: BAYER INTELLECTUAL PROPERTY GMBH
- Current Assignee Address: DE Monheim
- Agency: Morrison & Foerster LLP
- Priority: EP11167317 20110524; EP11180759 20110909; EP12158030 20120305
- International Application: PCT/EP2012/059399 WO 20120521
- International Announcement: WO2012/160034 WO 20121129
- Main IPC: C07D251/42
- IPC: C07D251/42 ; C07D251/44 ; C07D405/04 ; A61K31/53 ; A61P35/00 ; C07D251/16 ; C07D251/22 ; C07D401/12 ; C07D405/12 ; C07D413/12 ; C07D417/12 ; C07C381/10
Abstract:
The present invention relates to 4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group of general formula (I) or (Ia) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorders, in particular of hyper-proliferative disorders and/or virally induced infectious diseases and/or of cardiovascular diseases. The invention further relates to intermediate compounds useful in the preparation of said compounds of general formula (I) or (Ia).
Public/Granted literature
- US20140315906A1 4-ARYL-N-PHENYL-1,3,5-TRIAZIN-2-AMINES CONTAINING A SULFOXIMINE GROUP Public/Granted day:2014-10-23
Information query
